Click here to read the Cover Story, “More treatments expand personalized ankle cartilage repair.”A middle-aged, active patient — the kind who alternates between running along the canals and cycling ...

In a global breakthrough, PGIMER researchers have developed a robotic, PET-CT guided injection technique that offers ...

A single shot into a damaged joint reversed osteoarthritis in animals within weeks, according to researchers at the ...

Phage therapies present growth opportunities by leveraging their specificity against antibiotic-resistant bacteria, offering customizable treatments with minimal microbiome disruption. Key areas ...

Live audio of the virtual event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcast will also be available for two weeks following ...

Healthy mice receiving injections of nerve growth factor (NGF) into their knee joints developed multiple joint abnormalities ...

Renovare Therapeutics, Inc., a privately-held biotechnology company pioneering regenerative therapeutics for osteoarthritis, today announced its formal launch from stealth mode and collaboration with ...

Joint pain is one of the most common medical complaints affecting people of all ages. While many consider it a normal part of ...

IND Filing and Concurrent RMAT Request Position XytriX™ as a Potential Breakthrough Biotherapeutic for More Than 500 ...

A systematic analysis published in the Journal of Bioresources and Bioproducts establishes functionalized microalgae as ...

Detailed price information for Pacira Pharm Inc (PCRX-Q) from The Globe and Mail including charting and trades.

Knee osteoarthritis (KOA) is a prevalent degenerative joint disease worldwide. Current treatments primarily offer only symptomatic relief and lack disease-modifying efficacy. Photobiomodulation ...